Poly Medicure Ltd Falls 8.50% Amid Margin Pressures and Volatility: 5 Key Factors Driving the Week

2 February: Stock Hits 52-Week Low Amid Market Pressures

Poly Medicure Ltd’s share price declined sharply on 2 February 2026, touching a fresh 52-week low of Rs.1,445.4. The stock closed at Rs.1,451.10, down 4.40% for the day, underperforming the Sensex which fell 1.03%. This drop reflected sustained sectoral weakness in Medical Equipment/Supplies/Accessories, which declined 3.45% that day. The stock’s fall below all key moving averages signalled a bearish technical setup, exacerbated by valuation concerns despite a 22.8% profit growth over the past year. Institutional holdings of 23.24% suggest some confidence, but the overall market sentiment was cautious.

3 February: Sharp Rebound with Gap Up and Intraday High

Following two days of declines, Poly Medicure Ltd staged a notable recovery on 3 February, opening with a strong gap up of 6.74% and reaching an intraday high of Rs.1,579, an 8.81% increase from the previous close. The stock closed at Rs.1,587.60, up 9.41%, outperforming both its sector’s 4.85% gain and the Sensex’s 2.63% rise. This rally indicated a short-term shift in market sentiment, possibly driven by bargain hunting or positive trading momentum. However, the stock remained below longer-term moving averages, suggesting resistance to a sustained breakout. Technical indicators such as MACD and Bollinger Bands remained bearish, reflecting underlying caution despite the intraday strength.

5 February: Quarterly Results Reveal Profit Decline Despite Revenue Growth

Poly Medicure Ltd reported its Q3 FY26 results on 5 February, posting record quarterly net sales of Rs.493.66 crores, the highest in its history. However, profitability suffered as profit after tax (PAT) declined 11.0% to Rs.75.86 crores, with earnings per share (EPS) falling to Rs.7.00. Operating margins compressed to 22.52%, the lowest in recent quarters, signalling rising costs and margin pressures. The debtors turnover ratio also deteriorated to 4.02 times, indicating slower receivables collection and potential working capital challenges. These results contributed to a negative shift in the company’s financial trend score from flat to -8, prompting a downgrade in the Mojo Grade to Strong Sell with a score of 28.0.

6 February: Stock Hits Fresh 52-Week Low Amid Heavy Selling Pressure

On 6 February, Poly Medicure Ltd’s stock fell sharply again, hitting a new 52-week low of Rs.1,395 intraday and closing at Rs.1,388.85, down 7.40% for the day. This marked the third consecutive session of declines, with a cumulative loss of 11.84% over three days. The stock underperformed its sector, which declined 5.12%, and the broader market, with the Sensex gaining 0.10%. Intraday volatility was elevated at 5.26%, reflecting heightened uncertainty. The stock traded below all major moving averages, reinforcing the bearish technical outlook. Despite the broader market’s resilience, Poly Medicure’s price action highlighted company-specific challenges, including margin pressures and deteriorating operational metrics.

Key Takeaways from the Week

1. Volatile Price Action Reflects Mixed Sentiment: The stock’s sharp swings, including a strong rebound on 3 February followed by renewed declines, indicate uncertainty among investors amid conflicting signals from technicals and fundamentals.

2. New 52-Week Lows Signal Bearish Momentum: The stock breached fresh lows twice during the week, closing near Rs.1,388.85, underscoring sustained selling pressure and technical weakness below all major moving averages.

3. Quarterly Results Highlight Margin Compression: Despite record sales of Rs.493.66 crores, profit fell 11%, with operating margins dropping to 22.52%. This margin squeeze raises concerns about cost control and profitability sustainability.

4. Underperformance Relative to Sensex and Sector: While the Sensex gained 1.51% over the week, Poly Medicure declined 8.50%, underperforming the Medical Equipment/Supplies sector which also faced pressure but to a lesser extent.

5. Strong Institutional Holdings Amid Cautious Outlook: Institutional investors hold 23.24% of the stock, reflecting some confidence, but the downgrade to a Strong Sell Mojo Grade and deteriorating financial trend suggest caution remains warranted.

Conclusion: A Challenging Week Amid Margin and Technical Headwinds

Poly Medicure Ltd’s week was characterised by significant volatility, fresh 52-week lows, and disappointing quarterly earnings that revealed margin pressures despite record revenue growth. The stock’s 8.50% weekly decline contrasted sharply with the Sensex’s 1.51% gain, highlighting company-specific challenges. Technical indicators remain bearish with the stock trading below all key moving averages, while fundamental concerns around profitability and working capital management persist. Institutional investors maintain a sizeable stake, but the downgrade to a Strong Sell rating by MarketsMOJO reflects the cautious market stance. Overall, the week’s developments underscore the need for close monitoring of margin recovery and operational efficiency before a sustained turnaround can be expected.

Unlock special upgrade rates for a limited period. Start Saving Now →